Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

ELEKTA B

EKTAb.STSE0000163628NASDAQ StockholmSESEK
Stock price
ELEKTA B
Loading chart...

Coverage

Latest articles

New Elekta CEO ousts three top executives in management shake-up
8 Sept 2025, 05:32EKTAb.STNASDAQ Stockholm

Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.

Elekta links executive pay to advanced technology sales
4 Sept 2025, 14:59EKTAb.STNASDAQ Stockholm

Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.

New Elekta CEO faces pressure as margins and sales fall
28 Aug 2025, 05:33EKTAb.STNASDAQ Stockholm

Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.

Elekta gets epilepsy nod amid strategic overhaul
6 Aug 2025, 20:16EKTAb.STNASDAQ Stockholm

Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.

Elekta clears deck for new CEO with order cancellation
11 Jun 2025, 20:13EKTAb.STNASDAQ Stockholm

Swedish medical technology company Elekta has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.

Elekta appoints Jakob Just-Bomholt as new president and CEO
11 Jun 2025, 19:29EKTAb.STNASDAQ Stockholm

Elekta announced Monday that its Board of Directors has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.

  • Previous
  • 1
  • 2

Filings

Recent filings

FilingDate
Elekta presents long-term strategy and financial scenario at capital markets day27 Sept 2018
Bulletin from Elekta’s annual general meeting 201830 Aug 2018
Interim report May-July 2018/1930 Aug 2018
Elekta's annual report for 2017/18 available9 Aug 2018
Elekta Unity is pending 510(k) with the FDA for U.S. sales and clinical use clearance7 Aug 2018
Welcome to the Annual General Meeting of shareholders of Elekta AB (publ)31 Jul 2018
Elekta Unity, world’s first high-field MR-linac, receives CE mark18 Jun 2018
Elekta Nomination Committee’s proposed Board of Directors for the 2018 Annual General Meeting12 Jun 2018
Year-end report May-April 2017/181 Jun 2018
Proton Partners International to acquire Elekta MR-linac cancertreatment devices21 Apr 2018
Interim report May-January 2017/182 Mar 2018
The Ottawa Hospital acquires several Elekta Versa HD devices for advanced cancer treatment31 Jan 2018
  • Previous
  • 1
  • More pages
  • 15
Search
Company
ELEKTA B
EKTAb.STNASDAQ Stockholm
Website: Unavailable
Coverage
12
  • Next
  • 16
  • 17
  • More pages
  • 59
  • Next
  • Filings
    703